featured
Neoadjuvant Degarelix With or Without Apalutamide Before Radical Prostatectomy for High-Risk Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
European Urology
ARNEO: A Randomized Phase II Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer
Eur Urol 2022 Sep 24;[EPub Ahead of Print], G Devos, L Tosco, M Baldewijns, et alAdvanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.